Five School of Pharmacy researchers in first cohort of Chan Zuckerberg Biohub Investigators
Fifteen UC San Francisco faculty members have been named to the first cohort of Chan Zuckerberg Biohub Investigators, including five from the School of Pharmacy.
The CZ Biohub is an independent nonprofit research organization formed as a collaboration between UCSF, UC Berkeley and Stanford University with the goal of inventing new tools to accelerate transformative advances in the life sciences. CZ Biohub is funded by a $600 million commitment from Facebook CEO and founder Mark Zuckerberg and pediatrician Priscilla Chan, and it is the first philanthropic science investment made by the Chan Zuckerberg Initiative, which is dedicated to advancing human potential and promoting equality.
The first cohort of CZ Biohub Investigators includes 47 faculty members from the three universities. The group includes both highly accomplished senior professors as well as up-and-coming young faculty.
UCSF has nine senior investigators and six junior investigators in the cohort; the senior investigators include these five faculty members from the School of Pharmacy:
Adam Abate, PhD, Department of Bioengineering and Therapeutic Sciences
Zev Gartner, PhD, Department of Pharmaceutical Chemistry
Bo Huang, PhD, Department of Pharmaceutical Chemistry
Tanja Kortemme, PhD, Department of Bioengineering and Therapeutic Sciences
James Wells, PhD, Department of Pharmaceutical Chemistry
Read the full story:
About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American West. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.